TF Supplements of Houston is recalling Rhino supplements because they contain undeclared drugs that can pose a serious health risk. Consumers who have purchased these products should not use them as serious health risks are possible. There has been at least one adverse health event associated with these products.
The following products are included in the recall: all lot numberts of RHINO 7 3000 capsules in bottles containing six (6) capsules with the UPC: 616453150126 ; andRhino 7 Platinum 3000 Capsules packaged in a single (1) blister packs hang card count UPC: 700729253748.
The U.S. Food and Drug Administration (FDA) has determined that these products contain undeclared desmethyl carbondenafil and dapoxetine. “Desmethyl carbondenafil is a phosphodiesterase PDE-5 inhibitor which is a class of drugs used to treat male erectile dysfunction, making these products unapproved new drugs. Dapoxetine is an active ingredient not approved by the U.S. Food and Drug Administration (FDA),” according to the recall.
Desmethyl carbondenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels that can be life threatening. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. These patients are at serious risk.
Because Dapoxetine has not been approved by the FDA, its safety or efficacy has not been established. Chemically, it belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs) used to treat depression. Consuming these products presents a health risk which could be life threatening.
TF Supplements has discontinued sales of these products which are marketed as dietary supplements for sexual enhancement. The company is notifying its customers via e-mail of this voluntary recall. Consumers who have purchased these products should stop using them immediately. They can be returned to the company for a refund.